The family of Alice Webb, who died after having a liquid BBL, have called for restrictions on who can carry out the cosmetic procedure ...

FDA approves Hibsago (bepirovirsen) with NrtI therapy for adult chronic hepatitis B without cirrhosis; phase 3 trials show up to 20% functional cure at 72 weeks.

Some adults with chronic hepatitis B may now have a path to something today's treatments rarely deliver—stopping all ...

Today we shine a light on a study that suggests just how ​misguided and potentially dangerous new US hepatitis B vaccination ...

The findings run counter to updated guidance issued in January 2025 by the U.S. Centers for Disease Control and Prevention ...

Top Democrats on the House Energy and Commerce Committee demanded answers Thursday from the Centers for Disease Control and ...

Doctor of health science Vincent Candrawinata told nine.com.au there are some key things to look out for when choosing a nail ...

The approval of Hibsago has created a new market for a handful of biopharmas, including Gilead, Arrowhead, and Vir, to fill ...

Arbutus Biopharma (ABUS) said Thursday the US Food and Drug Administration lifted a clinical hold on its AB-101 treatment for hepatitis B, letting the company run further trials o ...

Two viruses can attack the same organ, yet the way they spread and the damage they cause are remarkably different. While ...

For the first time, many people living with chronic hepatitis B may have a functional cure at hand. The US Food and Drug ...

Changes to federal hepatitis B vaccination recommendations could lead to more childhood infections, according to a new study published Monday.